State Street’s Biodesix BDSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$258K Hold
17,802
﹤0.01% 3830
2025
Q4
$121K Buy
17,802
+2,400
+16% +$17.7K ﹤0.01% 4009
2025
Q3
$116K Sell
15,402
-1
-0% -$8 ﹤0.01% 4025
2025
Q2
$86.9K Hold
15,403
﹤0.01% 4002
2025
Q1
$193K Hold
15,403
﹤0.01% 3834
2024
Q4
$471K Buy
15,403
+975
+7% +$28.7K ﹤0.01% 3634
2024
Q3
$514K Hold
14,428
﹤0.01% 3590
2024
Q2
$441K Buy
14,428
+660
+5% +$18.8K ﹤0.01% 3584
2024
Q1
$394K Hold
13,768
﹤0.01% 3706
2023
Q4
$507K Hold
13,768
﹤0.01% 3640
2023
Q3
$454K Hold
13,768
﹤0.01% 3690
2023
Q2
$339K Buy
13,768
+12,565
+1,044% +$377K ﹤0.01% 3824
2023
Q1
$44.7K Hold
1,203
﹤0.01% 4529
2022
Q4
$55.3K Buy
1,203
+555
+86% +$15.1K ﹤0.01% 4536
2022
Q3
$16K Sell
648
-250
-28% -$9.64K ﹤0.01% 4851
2022
Q2
$29K Sell
898
-6,084
-87% -$198K ﹤0.01% 4824
2022
Q1
$236K Buy
6,982
+134
+2% +$8.76K ﹤0.01% 4323
2021
Q4
$724K Buy
6,848
+35
+0.5% +$4.57K ﹤0.01% 3893
2021
Q3
$1.12M Buy
6,813
+1,832
+37% +$347K ﹤0.01% 3756
2021
Q2
$1.32M Buy
4,981
+3,042
+157% +$956K ﹤0.01% 3617
2021
Q1
$788K Buy
1,939
+222
+13% +$99.2K ﹤0.01% 3671
2020
Q4
$692K Buy
+1,717
New +$535K ﹤0.01% 3612

Other funds holding BDSX

State Street's BDSX Position: Q1 2026 in Review

State Street held its Biodesix (BDSX) position steady in Q1 2026 at 17,802 shares worth $258K. The position accounts for ﹤0.01% of the portfolio, ranked #3830.

State Street first reported a position in BDSX in Q4 2020 and has held it in 22 quarters since. The position peaked at $1.32M in Q2 2021. 40 funds tracked by Wall St. Rank hold BDSX as of Q1 2026.

  • State Street held 17,802 shares of Biodesix worth $258K as of Q1 2026.
  • State Street left its Biodesix share count unchanged in Q1 2026.
  • Biodesix made up ﹤0.01% of State Street's portfolio in Q1 2026, its #3830 holding.
  • State Street first reported a position in Biodesix in Q4 2020 and has held it in 22 quarters since.
  • State Street's Biodesix position peaked at $1.32M in Q2 2021.
  • 40 funds tracked by Wall St. Rank held Biodesix as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.